Cryptococcosis Market, By Treatment (Amphotericin B, Flucytosine, Fluconazole, Voriconazole, Surgery Treatment, Others), By Diagnosis (Bronchoscopy, X-ray, MRI, Lung Biopsy, CSF Polymerase Chain Reaction (PCR), CT Scan, Others), By End-Users (Clinic, Hospital, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

The regions that make up the global cryptococcosis market are Latin America, North America, Europe, Asia Pacific, and the Middle East and Africa. The global market for cryptococcosis is expected to be dominated by North America due to the region's higher rates of infection, advancements in technology, and more significant expense of treatment. For example, a 2019 National Institutes of Health report estimates that the prevalence of cryptococcosis in the U.S. is between 0.4 and 1.3 cases per 100,000 in the general population and between 2 and 7 cases per 100,000 in AIDS-positive individuals, with a case fatality ratio of roughly 12%. North America holds a substantial market share because of the heightened occurrence of cryptococcosis in endemic areas, which is boosting.